Patents by Inventor Claudio Argento

Claudio Argento has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210251806
    Abstract: The present technology relates to intraocular shunting systems and methods. In some embodiments, the present technology includes intraocular shunting systems that include a drainage element having an inflow portion configured for placement within an anterior chamber of the eye outside of an optical field of view of the patient and an outflow portion configured for placement at a different location of the eye. The system can also include a flow control assembly having a rotational control element operably coupled to the drainage element. The flow control assembly can further include an actuation structure coupled to the rotational control element and configured to selectively change an orientation of the rotational control element. An amount of fluid through the inflow portion and/or the outflow portion can vary based on the selected orientation of the rotational control element.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 19, 2021
    Inventors: Eric Schultz, Robert Chang, Tom Saul, Richard Lilly, Michael Drews, Claudio Argento, Katherine Sapozhnikov
  • Patent number: 11065109
    Abstract: An accommodating intraocular lens (AIOL) for implantation within a capsular bag of a patient's eye comprises first and second components coupled together to define an inner fluid chamber and an outer fluid reservoir. The inner region of the AIOL provides optical power with one or more of the shaped fluid within the inner fluid chamber or the shape of the first or second components. The fluid reservoir comprises a bellows region with fold(s) extending circumferentially around an optical axis of the eye. The bellows engages the lens capsule, and a compliant fold region between the inner and outer bellows portions allows the profile of the AIOL to deflect when the eye accommodates for near vision. Fluid transfers between the inner fluid chamber and the outer fluid reservoir to provide optical power changes. A third lens component coupled to the first or second component provides additional optical power.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: July 20, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Claudio Argento, Tom Saul
  • Patent number: 11058581
    Abstract: Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: July 13, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Publication number: 20210205590
    Abstract: The present technology is directed to adjustable interatrial shunting systems that selectively control blood flow between the left atrium and the right atrium of a patient. The adjustable interatrial devices include a shunting element having an outer surface configured to engage native tissue and an inner surface defining a lumen that enables blood to flow from the left atrium to the right atrium when the system is deployed across the septal wall. The systems can include an actuation assembly for selectively adjusting a geometry of the lumen and/or a geometry of a lumen orifice to control the flow of blood through the lumen.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 8, 2021
    Inventors: Brian Fahey, Scott Robertson, William L. Gould, William Jason Fox, Claudio Argento, Anthony Pantages, Miles Alexander, Peter Andriola
  • Publication number: 20210154009
    Abstract: Systems, devices, and methods for treating a diseased native valve in a patient, the system comprising a compressible and expandable frame structure and an anchor. The anchor comprises a wire having a free end and is configured to be fully advanced from an atrial side of a native valve in a patient into a ventricle of the heart and anchor the frame structure to the native valve when the frame structure is in the expanded configuration adjacent the native valve.
    Type: Application
    Filed: February 8, 2021
    Publication date: May 27, 2021
    Inventors: Claudio ARGENTO, Andrew BACKUS, Alice YANG
  • Patent number: 10987214
    Abstract: An accommodating intraocular lens (AIOL) for implantation within a capsular bag of a patient's eye comprises first and second components coupled together to define an inner fluid chamber and an outer fluid chamber. The inner region of the AIOL provides optical power with one or more of the shaped fluid within the inner fluid chamber or the shape of the first or second components. A surface treatment or coating may be applied to one or more surfaces of the first and second components. The surface treatment is expected to decrease the roughness of the machined surfaces of the boundary surfaces of the first and second components, and thereby reduce the mass of water coalescing at such boundary surfaces. The disclosed surface treatments are also expected to increase the hydrophobicity (i.e., decrease the surface energy) of the corresponding surface(s), thereby decreasing the “wettability” of these surfaces.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: April 27, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Claudio Argento, Syed Hasan Askari, Arindam Datta, Jacob Raquet, Tom Saul
  • Publication number: 20210085935
    Abstract: The present technology is directed to adjustable interatrial shunting systems that selectively control blood flow between the left atrium and the right atrium of a patient. The adjustable interatrial devices include a shunting element having an outer surface configured to engage native tissue and an inner surface defining a lumen that enables blood to flow from the left atrium to the right atrium when the system is deployed across the septal wall. The systems can include an actuation assembly for selectively adjusting a geometry of the lumen and/or a geometry of a lumen orifice to control the flow of blood through the lumen.
    Type: Application
    Filed: September 9, 2020
    Publication date: March 25, 2021
    Inventors: Brian Fahey, Scott Robertson, William L. Gould, William Jason Fox, Claudio Argento, Anthony Pantages, Miles Alexander, Peter Andriola
  • Patent number: 10912644
    Abstract: Systems, devices, and methods for treating a diseased native valve in a patient, the system comprising a compressible and expandable frame structure and an anchor. The anchor comprises a wire having a free end and is configured to be fully advanced from an atrial side of a native valve in a patient into a ventricle of the heart and anchor the frame structure to the native valve when the frame structure is in the expanded configuration adjacent the native valve.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: February 9, 2021
    Assignee: Shifamed Holdings, LLC
    Inventors: Claudio Argento, Andrew Backus, Alice Yang
  • Publication number: 20200297491
    Abstract: A system for treating a diseased native valve in a patient includes a valve prosthesis and a delivery device. The prosthesis includes an anchor and a frame. The delivery device includes an outer sheath, an inner shaft, an anchor guide, and a tether. The anchor is shaped to encircle chordae or leaflets of a native valve. The frame is configured to sit within the anchor. The inner shaft is positioned within the outer sheath and translatable and rotatable relative to the outer sheath. The anchor guide is attached to a distal end of the inner shaft and has a curved distal section. The tether is configured to detachably couple to the anchor and to longitudinally translate the anchor within the inner shaft and anchor guide. The anchor is configured to be actuated from a delivery configuration to the deployed configuration when the anchor is translated out of the anchor guide.
    Type: Application
    Filed: March 19, 2020
    Publication date: September 24, 2020
    Inventors: Claudio ARGENTO, Andrew BACKUS, Alice YANG, Ali SALAHIEH, Jasper Ellington ADAMEK-BOWERS, Connor MULCAHY, Ryan William BOYD, Nicholas SPINELLI, Tom SAUL
  • Publication number: 20200261220
    Abstract: A heart valve prosthesis for replacing a diseased native valve in a patient, the valve includes a compressible and expandable frame structure and an anchor connected to an outer periphery of the frame structure. The anchor comprises a free end and has a flat spiral shape. The valve may further include a valve segment mounted within the frame structure and expanded with the frame structure. The frame structure may be configured for receiving a valve segment.
    Type: Application
    Filed: December 20, 2019
    Publication date: August 20, 2020
    Applicant: Shifamed Holdings, LLC
    Inventors: Claudio ARGENTO, Andrew BACKUS, Alice YANG
  • Publication number: 20200229928
    Abstract: Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension to the anchor may draw the first and second walls of the heart into contact along a desired contour so as to effect a desired change in the geometry of the heart. Additional anchors may be inserted and aligned with the first anchor to close off a portion of a ventricle such that the ventricle is geometrically remodeled and disease progression is reversed, halted, and/or slowed.
    Type: Application
    Filed: April 2, 2020
    Publication date: July 23, 2020
    Applicant: BioVentrix, Inc.
    Inventors: Lon S. Annest, Claudio Argento, William Butler, Ernest Heflin
  • Publication number: 20200229981
    Abstract: Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Publication number: 20200229977
    Abstract: Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.
    Type: Application
    Filed: July 20, 2018
    Publication date: July 23, 2020
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Publication number: 20200229982
    Abstract: Systems and devices for facilitating the flow of fluid between a first body region and a second body region are disclosed herein. The devices generally include a drainage and/or shunting element having a lumen extending therethrough for draining or otherwise shunting fluid between the first and second body regions. Further, devices configured in accordance with the present technology may be selectively adjustable to control the amount of fluid flowing between the first and second body regions. In some embodiments, for example, the devices comprise an actuation assembly that drives movement of a flow control element to modulate flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of fluid between the first body region and the second body region.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Inventors: Colin Mixter, Claudio Argento, Andrew Backus, Tom Saul
  • Patent number: 10709549
    Abstract: An accommodating intraocular lens comprises a first lens component, a second lens component, and an adhesive between portions of the two lens components. The cured adhesive bonds the lens components to form a fluid chamber. The lens components are bonded to one another along a seam which extends circumferentially along at least a portion of the lens components. The lens components may comprise the same polymer material. The cured adhesive also comprises the polymer or a prepolymer of the polymer to provide increased strength. The polymer is hydratable such that the lens components and the cured adhesive therebetween can swell together to inhibit stresses between the lens components and the cured adhesive.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: July 14, 2020
    Assignee: Shifamed Holdings, LLC
    Inventors: Claudio Argento, Bob Vaughan, Amr Salahieh, Tom Saul, Eric Willis
  • Publication number: 20200163756
    Abstract: Intraocular lens delivery devices and methods of use.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Applicant: PowerVision, Inc.
    Inventors: Daniel HILDEBRAND, Claudio ARGENTO, Gregory Vinton MATTHEWS
  • Publication number: 20200146813
    Abstract: The present technology is directed to an adjustable power intraocular lens comprising a container, an optical fluid in the container, and a transport substance in solution with the optical fluid. The container has an optical component and a peripheral component extending around at least a portion of the optical component. The optical component has an anterior optical element, a posterior optical element, and a fluid chamber having a chamber volume between the anterior optical element and the posterior optical element. The transport substance is configured to pass through the container. The adjustable power intraocular lens further comprises volume control elements in the container. The volume control elements are configured to be activated by a non-invasive energy and upon activation release the transport substance into the optical fluid to decrease the chamber volume and/or absorb the transport substance from the optical fluid to increase the chamber volume.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 14, 2020
    Inventors: Claudio Argento, Tom Saul, Colin Mixter
  • Publication number: 20200121447
    Abstract: An accommodating intraocular lens (AIOL) for implantation within a capsular bag of a patient's eye comprises first and second components coupled together to define an inner fluid chamber and an outer fluid chamber. The inner region of the AIOL provides optical power with one or more of the shaped fluid within the inner fluid chamber or the shape of the first or second components. A surface treatment or coating may be applied to one or more surfaces of the first and second components. The surface treatment is expected to decrease the roughness of the machined surfaces of the boundary surfaces of the first and second components, and thereby reduce the mass of water coalescing at such boundary surfaces. The disclosed surface treatments are also expected to increase the hydrophobicity (i.e., decrease the surface energy) of the corresponding surface(s), thereby decreasing the “wettability” of these surfaces.
    Type: Application
    Filed: May 29, 2018
    Publication date: April 23, 2020
    Inventors: Claudio Argento, Syed Hasan Askari, Arindam Datta, Jacob Raquet, Tom Saul
  • Patent number: 10624744
    Abstract: Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension to the anchor may draw the first and second walls of the heart into contact along a desired contour so as to effect a desired change in the geometry of the heart. Additional anchors may be inserted and aligned with the first anchor to close off a portion of a ventricle such that the ventricle is geometrically remodeled and disease progression is reversed, halted, and/or slowed.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: April 21, 2020
    Assignee: BioVentrix, Inc.
    Inventors: Lon S. Annest, Claudio Argento, William Butler, Ernest Heflin
  • Publication number: 20200107930
    Abstract: Systems, devices, and methods for treating a diseased native valve in a patient, the system comprising a compressible and expandable frame structure and an anchor. The anchor comprises a wire having a free end and is configured to be fully advanced from an atrial side of a native valve in a patient into a ventricle of the heart and anchor the frame structure to the native valve when the frame structure is in the expanded configuration adjacent the native valve.
    Type: Application
    Filed: October 7, 2019
    Publication date: April 9, 2020
    Inventors: Claudio ARGENTO, Andrew Backus, Alice Yang